...
首页> 外文期刊>Thrombosis Research: An International Journal on Vascular Obstruction, Hemorrhage and Hemostasis >Chronic viral hepatitis C, oxidative stress and the coagulation/fibrinolysis system in haemodialysis patients.
【24h】

Chronic viral hepatitis C, oxidative stress and the coagulation/fibrinolysis system in haemodialysis patients.

机译:血液透析患者的慢性丙型肝炎病毒,氧化应激和凝血/纤溶系统。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

INTRODUCTION: The aim of the present study was to establish whether the presence of chronic viral hepatitis (PVH) could be implicated in the elevation of oxidative stress (SOX) and haemostasis system in haemodialysis (HD) patients. MATERIALS AND METHODS: In HD patients with and without PVH and in controls we compared the markers of: coagulation pathway- tissue factor (TF) and its inhibitor (TFPI), prothrombin fragment F (1+2) (F (1+2)); fibrinolysis: tissue-type plasminogen activator (tPA), urokinase-type plasminogen activator (uPA) and its soluble receptor (suPAR), plasminogen activator inhibitor 1 (PAI-1), plasmin/antiplasmin complexes (PAP); and a marker of SOX-Cu/Zn superoxide dismutase (Cu/Zn SOD) levels. RESULTS: Patients, particularly those with PVH, showed a significant increase in the markers of the coagulation, fibrinolysis and oxidative status as compared to controls. All parameters of coagulation/fibrinolysis system were directly associated with the PVH and Cu/Zn SOD levels, and there was a relationship between the PVH and Cu/Zn SOD levels. Multivariable analysis showed that PVH and increased SOX were identified as independent variables significantly associated with the disturbances of coagulation/fibrinolysis system in these patients. CONCLUSIONS: We concluded that PVH is a novel determinant of the increased oxidative stress as well as the disturbances of coagulation/fibrinolysis system in haemodialysis patients.
机译:引言:本研究的目的是确定慢性病毒性肝炎(PVH)的存在是否可能与血液透析(HD)患者的氧化应激(SOX)和止血系统的升高有关。材料与方法:在患有和不患有PVH的HD患者中和对照组中,我们比较了以下标记物:凝血途径-组织因子(TF)及其抑制剂(TFPI),凝血酶原片段F(1 + 2)(F(1 + 2) );纤维蛋白溶解:组织型纤溶酶原激活物(tPA),尿激酶型纤溶酶原激活物(uPA)及其可溶性受体(suPAR),纤溶酶原激活物抑制剂1(PAI-1),纤溶酶/抗纤溶酶复合物(PAP);以及SOX-Cu / Zn超氧化物歧化酶(Cu / Zn SOD)水平的标志物。结果:与对照组相比,患者,特别是患有PVH的患者,其凝血,纤维蛋白溶解和氧化状态的标志物显着增加。凝血/纤溶系统的所有参数都与PVH和Cu / Zn SOD水平直接相关,并且PVH和Cu / Zn SOD水平之间存在关系。多变量分析表明,PVH和SOX升高是与这些患者凝血/纤溶系统紊乱显着相关的独立变量。结论:我们得出结论,PVH是血液透析患者氧化应激增加以及凝血/纤维蛋白溶解系统紊乱的新决定因素。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号